Status:
UNKNOWN
ERAS Versus ERAS Plus Artificial Nutrition in Open Pancreatoduodenectomy
Lead Sponsor:
University of Milano Bicocca
Conditions:
Pancreas Disease
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
there is a need of a randomised clinical trial specifically design to explore whether given a full nutritional requirement by parenteral feeding in the first 5 days after surgery coupled with oral foo...
Detailed Description
Background The enhanced recovery after surgery (ERAS) protocol is currently considered the gold-standard clinical pathway for perioperative care (1). This protocol is a bundle of interventions derive...
Eligibility Criteria
Inclusion
- Adult patients (age ≥ 18 and \< 90 years of age) candidate to elective pancreatoduodenectomy for any periampullary or pancreatic cancer
Exclusion
- American Society of Anaesthesiologists (ASA) physical status classification \> 3
- Weight loss \> 15% with respect to usual weight in the last 6 months
- Child-Pugh \> A
- Not signed consent
- Palliative surgery
- Placement of a naso-enteric or jejunostomy feeding tube
Key Trial Info
Start Date :
April 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT04438447
Start Date
April 14 2022
End Date
December 31 2022
Last Update
December 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Milano-Bicocca
Monza, Italy, 20900